Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer
Authors
Keywords
Prostate cancer, MicroRNAs, Cancer detection and diagnosis, Gene expression, Biomarkers, Messenger RNA, Metastasis, Prognosis
Journal
PLoS One
Volume 12, Issue 9, Pages e0184094
Publisher
Public Library of Science (PLoS)
Online
2017-09-15
DOI
10.1371/journal.pone.0184094
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer-derived Circulating MicroRNAs Promote Tumor Angiogenesis by Entering Dendritic Cells to Degrade Highly Complementary MicroRNAs
- (2017) Jiaqi Wang et al. Theranostics
- Impact of cause of death adjudication on the results of the European prostate cancer screening trial
- (2016) Stephen D Walter et al. BRITISH JOURNAL OF CANCER
- MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer
- (2016) Jiaqi Wang et al. Cancer Cell International
- Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review
- (2016) Edgars Endzeliņš et al. Molecular Cancer
- Circulating biomarkers to monitor cancer progression and treatment
- (2016) Suthee Rapisuwon et al. Computational and Structural Biotechnology Journal
- Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
- (2015) Guofeng Cheng ADVANCED DRUG DELIVERY REVIEWS
- Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion
- (2015) Wenqing Cao et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combinations of Serum Prostate-Specific Antigen and Plasma Expression Levels of let-7c, miR-30c, miR-141, and miR-375 as Potential Better Diagnostic Biomarkers for Prostate Cancer
- (2015) Darina Kachakova et al. DNA AND CELL BIOLOGY
- Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
- (2015) Xiaoyi Huang et al. EUROPEAN UROLOGY
- The combined serum levels ofmiR-375and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer
- (2015) Sven Wach et al. INTERNATIONAL JOURNAL OF CANCER
- miRNA Stability in Frozen Plasma Samples
- (2015) Francesca Balzano et al. MOLECULES
- miRWalk2.0: a comprehensive atlas of microRNA-target interactions
- (2015) Harsh Dweep et al. NATURE METHODS
- miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database
- (2015) Chih-Hung Chou et al. NUCLEIC ACIDS RESEARCH
- Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis
- (2015) Jianchun Wu et al. PLoS One
- Urinary biomarkers for the detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia
- (2015) Tamara Sequeiros et al. PROSTATE
- Elevated Serum MicroRNA Levels Associate with Absence of High-Grade Prostate Cancer in a Retrospective Cohort
- (2015) Brittany L. Mihelich et al. PLoS One
- Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs
- (2014) Kati Erdmann et al. BMC CANCER
- Expected population impacts of discontinued prostate-specific antigen screening
- (2014) Roman Gulati et al. CANCER
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis
- (2014) LaTanya V. Williams et al. PLoS One
- Comprehensive Study of Gene and microRNA Expression Related to Epithelial-Mesenchymal Transition in Prostate Cancer
- (2014) Betina Katz et al. PLoS One
- Circulating miRNAs 21 and 221 as biomarkers for early diagnosis of prostate cancer
- (2014) Sameh Kotb et al. TUMOR BIOLOGY
- PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-κB
- (2014) M Rodriguez et al. Oncogenesis
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Active Surveillance for Prostate Cancer: Overview and Update
- (2013) Laurence Klotz CURRENT TREATMENT OPTIONS IN ONCOLOGY
- miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1
- (2013) JUNJIE YU et al. ONCOLOGY REPORTS
- Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia
- (2013) Heather H. Cheng et al. PLoS One
- Identification and Validation of Reference Genes for qPCR Detection of Serum microRNAs in Colorectal Adenocarcinoma Patients
- (2013) Guixi Zheng et al. PLoS One
- Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells
- (2013) Minyi He et al. PROSTATE
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Changes in circulating microRNA levels associated with prostate cancer
- (2012) R J Bryant et al. BRITISH JOURNAL OF CANCER
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- MicroRNA and cancer
- (2012) Martin D. Jansson et al. Molecular Oncology
- Prostate-Cancer Mortality at 11 Years of Follow-up
- (2012) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics
- (2012) José A. March-Villalba et al. PLoS One
- Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer
- (2012) Jing Shen et al. PROSTATE
- MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening
- (2011) Sven Wach et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2
- (2011) Chang Zheng et al. MEDICAL ONCOLOGY
- Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
- (2011) Radha Duttagupta et al. PLoS One
- The Role of the Transcription Factor SIM2 in Prostate Cancer
- (2011) Bin Lu et al. PLoS One
- Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
- (2011) Fulya Yaman Agaoglu et al. TUMOR BIOLOGY
- Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
- (2011) Simpa S. Salami et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease
- (2010) Ugur Deligezer et al. CLINICA CHIMICA ACTA
- Molecular genetics of prostate cancer: new prospects for old challenges
- (2010) M. M. Shen et al. GENES & DEVELOPMENT
- Circulating miRNAs are correlated with tumor progression in prostate cancer
- (2010) Jan C. Brase et al. INTERNATIONAL JOURNAL OF CANCER
- Prostate cancer screening: current status and future perspectives
- (2010) Seth A. Strope et al. Nature Reviews Urology
- Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
- (2009) M. S. Arredouani et al. CLINICAL CANCER RESEARCH
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- (2009) S. A. Bustin et al. CLINICAL CHEMISTRY
- Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
- (2009) H. G. Welch et al. JNCI-Journal of the National Cancer Institute
- Both β-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer
- (2008) Ryutaro Mori et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now